Latest Lead News

Anteris Technologies has closed a $320 million capital raise, combining a $230 million public offering and a strategic private placement with Medtronic, to advance its DurAVR heart valve clinical trials and manufacturing growth.

Anteris Technologies Global Corp. has entered a material definitive agreement to raise approximately $320 million through a public offering and a strategic private placement with Medtronic’s subsidiary. The capital will support clinical trials and manufacturing expansion for its innovative heart valve technology.

Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.

Guzman y Gomez has secured a multi-year exclusive delivery partnership with Uber Eats in Australia, aiming to accelerate growth and enhance customer convenience. Delivery now accounts for over a quarter of GYG’s Australian sales, underscoring its strategic importance.

Arovella Therapeutics has filed an IND application for its lead CAR-iNKT therapy ALA-101, selected a CRO for its upcoming phase 1 trial, and secured $19.4 million in cash to fund clinical progress and pipeline expansion.

PYC Therapeutics has reported significant progress across its four RNA therapeutic programs targeting rare genetic diseases, supported by a strong cash position of $121 million at the end of 2025. Key clinical milestones and regulatory plans set the stage for upcoming trial readouts and potential market entry.

Coventry Group reports a solid half-year sales and earnings improvement while initiating a strategic review following unsolicited takeover interest.

Carnarvon Energy advances its Bedout Sub-basin exploration with a major drilling campaign planned for early 2027, while maintaining a robust financial position and strategic investment in Strike Energy.

Condor Energy Limited has advanced its offshore Peru portfolio with a new high-potential oil prospect and a strategic gas offtake agreement, positioning itself for future commercialisation in a promising basin.

Rox Resources has confirmed the economic viability of its Youanmi Gold Project with a robust feasibility study and commenced underground mining, backed by a $218 million equity raise. The company is on track for first gold production by mid-2027.

The ASX has released its latest list of entities suspended from trading for over three months, highlighting looming deadlines for report lodgement and trading resumption plans. Failure to meet these deadlines could lead to removal from the official list.

OZZ Resources has entered a binding option agreement with Scorpion Minerals to sell its Maguires Reward project, securing an initial $100,000 fee and potential $2.5 million consideration pending shareholder approval. Exploration activity remained subdued across its portfolio during the December quarter.